HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort

NCT05998499 | Completed

• 1 other identifier: HUIL_MI_VIH01
• Study Type: observational
• Target: 631
• Locations: 1 country
• Sites: 1

Brief Summary

This is a longitudinal observational study conducted in Europe that describes migrants infected with HIV from Latin America who come to Europe with the intention of seeking asylum or international protection. The aim of the study is to identify the barriers this population faces in accessing the healthcare system and to assess disease control

Conditions

HIV-1-infection; Sexually Transmitted Diseases

Keywords

Asylum Seekers; Migration; Europe; Latin America

Outcome Measures

Primary Outcomes (1)

• HIV viral control

  Number of participants with plasma HIV-1 RNA level of more than 50 copies per mL

  At inclusion

Secondary Outcomes (5)

• Resistance Pattern

  At inclusion

• Sexually transmited infections

  At inclusion

• Number and Type of Barriers to Accessing Healthcare

  At inclusion

• HIV viral control at 6 months

  6 months

• Retention in care

  6 months

Study Arms (1)

EuroLatin HIV Cohort (ELHC)

Cohort of Latin American migrants living with HIV who were seeking international protection in Spain (Europe)

Other: Description

Interventions

Description OTHER

This study aimed to understand the situation of Latin American HIV-positive migrants seeking asylum in Spain and identify the challenges they encounter in getting HIV treatment. The main result measured was the proportion of participants with an HIV-1 RNA level of 50 copies/mL or higher at their first clinic visit

EuroLatin HIV Cohort (ELHC)

Eligibility Criteria

• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Latin American migrants infected with HIV

You may qualify if:

• Latin American migrants infected with HIV who arrive in Spain with the intent to seek international protection and who lack access to healthcare.

You may not qualify if:

• Those who do not give their consent

Sponsors & Collaborators

• Hospital Universitario Infanta Leonor: lead

Study Sites (1)

Hospital Universitario Infanta Leonor

Madrid, 28031, Spain

Location

MeSH Terms

Conditions

Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Communicable Diseases; Infections; Genital Diseases; Urogenital Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Pablo Ryan Murua, MD, PhD

  Hospital Universitario Infanta Leonor

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 6 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: August 10, 2023
• First Posted: August 21, 2023
• Study Start: January 30, 2022
• Primary Completion: April 30, 2023
• Study Completion: July 15, 2023
• Last Updated: August 21, 2023

Record last verified: 2023-08

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: December, 2024
• Access Criteria: IP email

Locations

ES (1)